These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 7194172

  • 1. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin.
    Limpongsanurak S, Jenkins N, Fotherby K.
    Curr Med Res Opin; 1981; 7(3):185-91. PubMed ID: 7194172
    [Abstract] [Full Text] [Related]

  • 2. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S, Chen JK, He ML, Fotherby K.
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [Abstract] [Full Text] [Related]

  • 3. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L.
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [Abstract] [Full Text] [Related]

  • 4. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 5. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 6. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jan; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 8. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
    Miller JF, Fotherby K, Bye PG, Elstein M.
    Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
    [Abstract] [Full Text] [Related]

  • 9. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 10. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 11. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun 01; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 12. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 13. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep 01; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
    Crona N, Silfverstolpe G, Samsioe G.
    Contraception; 1984 Mar 01; 29(3):261-70. PubMed ID: 6234148
    [Abstract] [Full Text] [Related]

  • 15. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
    Sobbrio GA, Granata A, Granese D, D'Arrigo F, Panacea A, Nicita R, Pullè C, Trimarchi F.
    Clin Exp Obstet Gynecol; 1991 Mar 01; 18(1):43-5. PubMed ID: 1829029
    [Abstract] [Full Text] [Related]

  • 16. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L.
    Fertil Steril; 1984 Jul 01; 42(1):44-51. PubMed ID: 6233179
    [Abstract] [Full Text] [Related]

  • 17. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec 01; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V, Johannisson E, Landgren BM, Cekan SZ, Diczfalusy E.
    Contraception; 1983 Jul 01; 28(1):21-39. PubMed ID: 6414759
    [Abstract] [Full Text] [Related]

  • 19. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun 01; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF, Timmer CJ, Lammers P.
    Fertil Steril; 1994 Apr 01; 61(4):645-51. PubMed ID: 8150105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.